NITEL AM
Description
- Combination of Telmisartan (ARB) and Amlodipine (Calcium Channel Blocker)
- Provides enhanced blood pressure control through dual mechanism
- Reduces risk of heart attack, stroke, and kidney damage
- Offers once-daily dosing for 24-hour blood pressure management
- Effective for patients unresponsive to monotherapy
- Improves blood circulation and reduces arterial stiffness
- Well-tolerated with a favorable safety profile
Composition
TELMISARTAN-40 MG, AMLODIPINE-5 MG
Benefits
NITEL AM provides dual-action control over blood pressure by targeting different mechanisms responsible for hypertension. It ensures a more significant and sustained reduction in blood pressure, lowering the risk of heart attack, stroke, and kidney damage. This combination therapy is well-suited for patients who do not achieve adequate blood pressure control with monotherapy. Additionally, NITEL AM offers 24-hour protection with once-daily dosing, promoting better adherence and cardiovascular protection over the long term.
Introduction
NITEL AM is a powerful combination antihypertensive tablet containing Telmisartan 40 mg and Amlodipine 5 mg, designed to effectively manage high blood pressure (hypertension) and reduce the risk of cardiovascular events. Telmisartan is an angiotensin II receptor blocker (ARB) that relaxes blood vessels by blocking the effects of angiotensin II, while Amlodipine is a calcium channel blocker that widens blood vessels by relaxing the smooth muscles. Together, they work synergistically to lower blood pressure more effectively than either agent alone, making NITEL AM ideal for patients requiring combination therapy.
